Application effect of Daglijing combined with Valsartan Capsules in patients with type 2 diabetes mellitus complicated with newly developed hypertension
HAO Yan-hong1 WU Qing1 LI Yun2 WANG Ying-li1 ZHANG Ying1 LUO Ya-hui1 LIU Yan-dong1 ZHOU Li-jing1
1.Department of Endocrinology,Beijing Jiangong Hospital,Beijing 100054,China;
2.School of Public Health,the North China University of Science and Technology,Hebei Province,Tangshan 063210,China
Abstract：Objective To explore the effect of Daglijing combined with Valsartan Capsules in patients with type 2 diabetes mellitus complicated with newly developed hypertension.Methods A total of 92 patients with type 2 diabetes mellitus complicated with newly developed hypertension who were admitted to the Department of Endocrinology in Beijing Jiangong Hospital from January to December 2019 were selected as the research objects.All the patients were divided into combination therapy group and monotherapy group by the random number table method,with 46 cases in each group.Patients in the combination therapy group were treated with Daglijing combined with Valsartan Capsules,and patients in the monotherapy group were treated with Valsartan Capsules.After 24 weeks of treatment,the systolic blood pressure(SBP),diastolic blood pressure(DBP),mean artery pressure(MAP),SBP control rate,DBP control rate,and both control rate of the two groups were compared.Results A total of 41 patients in the combined treatment group and 40 patients in the monotherapy group were included in statistical analysis.There were no statistically significant differences in SBP,DBP,MAP before treatment between the two groups(P＞0.05).The SBP,DBP and MAP of the two groups after treatment were lower than those before treatment,and the differences were statistically significant(P＜0.05).The SBP,DBP and MAP of the combination therapy group after treatment were lower than those in the monotherapy group,and the differences were statistically significant(P＜0.05).After treatment,the SBP compliance rate and both compliance rates in the combined treatment group were higher than those in the monotherapy group,and the differences were statistically significant(P＜0.05).There was no statistical significance in DBP compliance rate between the two groups(P>0.05).Conclusion The clinical effect of Daglijing combined with Valsartan Capsules is better in patients with type 2 diabetes mellitus complicated with newly developed hypertension.
Paul M，Paul KW，Mark W，et al.A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S.Adults With Diabetes[J].Diabetes Care，2018，41（11）：2322-2329.
[6]
Gao N，Yuan Z，Tang X，et al.Prevalence of CHD-related metabolic comorbidity of diabetes mellitus in Northern Chinese adults：the REACTION study[J].Diabetes Complications，2016，30（2）：199-205.
Reboldi G，Gentile G，Angeli F，et al.Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes：a meta-analysis in 73 913 patients[J].J Hypertens，2011，29（7）：1253-1269.
京公网安备 11010502046607号